---
schema_version: "secwatch.filing_event.v1"
accession: "0000200406-24-000036"
form_type: "8-K/A"
ticker: "JNJ"
cik: "0000200406"
company_name: "JOHNSON & JOHNSON"
filed_at: "2024-04-16T23:59:59+00:00"
generated_at: "2026-06-03T22:27:31.469492+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "medium"
source: SEC EDGAR
---

# Johnson & Johnson corrects FY2024 operational sales guidance midpoint to $88.9B

## Summary
- Full-year 2024 operational sales guidance midpoint revised to $88.9B from $88.0B due to typo correction.
- Amendment No. 1 to Form 8-K filed April 16, 2024 corrects error in prior press release; no other changes.
- Press release for Q1 2024 (period ended March 31, 2024) otherwise unchanged; specifics not provided here.

## SEC filing metadata
- accession: 0000200406-24-000036
- form_type: 8-K/A
- ticker: JNJ
- cik: 0000200406
- company_name: JOHNSON & JOHNSON
- filed_at: 2024-04-16T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: medium
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/200406/000020040624000036/0000200406-24-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/200406/000020040624000036/jnj-20240416.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000200406-24-000036
- JSON: https://secwatch.observer/filing/0000200406-24-000036.json
- Plain text: https://secwatch.observer/filing/0000200406-24-000036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.